Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
314
NCT04248361
TEM-PCR™ Prospective Clinical Utility Study
Phase: Phase 4
Role: Lead Sponsor
Start: Mar 6, 2020
Completion: May 31, 2022